DNA topoisomerase I: Customs officer at the border between DNA and RNA worlds?

Journal of Molecular Medicine

Volumn 75, Issue 11-12, 1997, Pages 786-800

  Tazi, Jamal ^a,b   Rossi, Ferdinand ^a   Labourier, Emmanuel ^a   Gallouzi, Imed Edine ^a   Brunel, Claude ^a   Antoine, Etienne ^a  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

Alternative splicing; DNA topoisomerase I; mRNA precursor; Nucleus; Protein kinase; Protein phosphorylation; Small nuclear Ribonucleoprotein; Splicing factors

Indexed keywords

ANTINEOPLASTIC AGENT; DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR; MESSENGER RNA PRECURSOR; PROTEIN KINASE; SMALL NUCLEAR RIBONUCLEOPROTEIN;

ALTERNATIVE RNA SPLICING; ANTINEOPLASTIC ACTIVITY; DEVELOPMENT; DNA REPLICATION; GENETIC REGULATION; HUMAN; PROTEIN PHOSPHORYLATION; REVIEW;

EID: 0030828196     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050168     Document Type: Review

References (226)

1. Maniatis T (1991) Mechanisms of alternative pre-mRNA splicing. Science 251:33-34
2. Rio DC (1992) RNA binding proteins, splice site selection, and alternative pre-mRNA splicing. Gene expression 2:1-15
3. Nadal-Ginard B, Smith CW, Patton JG, Breitbart RE (1991) Alternative splicing is an efficient mechanism for generation of protein diversity: contractile protein genes as a model system. Adv Enzymol Regul 31:261-286
4. Ruby SW, Abelson J (1991) Pre-mRNA splicing in yeast. Trends Genet 7:79-83
5. Rymond BC, Rosbash M (1992) Yeast pre-mRNA splicing. In: Jones EWW, Pringle JR, Broach JR (eds) The molecular and cellular biology of yeast saccharomyces, vol 2. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 143-192
6. Moore MJ, Query CC, Sharp PA (1993) Splicing of precursors to mRNA by the spliceosome. In: Guesteland RF, Atkins JF (eds) RNA world, vol 1. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 303-357
7. Sharp PA (1994) Split genes and RNA splicing. Cell 77:805-815
8. Padgett, Grabowski PJ, Konarska MM, Seiler S, Sharp PA (1986) Splicing of messenger RNA precursors. Annu Rev Biochem 55:1119-1150
9. Green MR (1991) Biochemical mechanisms of constitutive and regulated pre-mRNA splicing. Ann Rev Cell Biol 7:559-599
10. Berget SM (1995) Exon recognition in vertebrate splicing. J Biol Chem 270:2411-2414
11. Fu XD (1995) The superfamily of arginine/serine-rich splicing factors. RNA 1:663-680
12. Manley JL, Tacke R (1996) SR proteins and splicing control. Genes Dev 10:1569-1579
13. Horowitz DS, Krainer AR (1994) Mechanisms for selecting 5′ splice sites in mammalian pre-mRNA splicing. Trends Genet 10:100-105
14. Mayeda A, Helfman DM, Krainer AR (1993) Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein Aland pre-mRNA splicing factor SF2/ASF. Mol Cell Biol 13:2993-3001
15. Zahler AM, Lane WS, Stolk JA, Roth MB (1992) SR proteins: a conserved family of pre-mRNA splicing factors. Genes Dev 6:837-847
16. Zuo P, Manley JL (1993) Functional domains of the human splicing factor ASF/SF2. EMBO J 12:4727-4737
17. Càceres JF, Krainer AR (1993) Functional analysis of premRNA splicing factor SF2/ASF structural domains. EMBO J 12:4715-4726
18. Zamore PD, Patton JG, Green MR (1992) Cloning and domain structure of the mammalian splicing factor U2AF. Nature 335:609-614
19. Roth MB, Zahler AM, Stolk JA (1991) A conserved family of nuclear phosphoproteins localized to sites of polymerase II transcription. J Cell Biol 115:587-591
20. Gui JF, Lane WS, Fu XD (1994) A serine kinase regulates intracellular localization of splicing factors in the cell cycle. Nature 369:678-682
21. Colwill K, Pawson T, Andrews B, Prasad J, Manley J, Bell JC, Duncan PI (1996) The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution. EMBO J 15:265-275
22. Romac MJ, Keene JD (1995) Overexpression of the argenine-rich carboxy-terminal region of U1 snRNP 70 K inhibits both splicing and nucleocytoplasmic transport of mRNA. Genes Dev 9:1400-1410
23. Fleischmann G, Pflugfelder G, Steiner EK, Javaherian K, Howard GC, Wang JC, Elgin SCR (1984) Drosophila DNA topoisomerase I is associated with transcriptionally active regions of the genome. Proc Natl Acad Sci USA 81:6958-6962
24. Gilmour DS, Pflugfelder G, Wang JC, Lis JT (1986) Topoisomerase I interacts with transcribed regions in Drosophila cells. Cell 44:401-407
25. Heck MM, Hittelman WN, Earnshaw WC (1988) Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proc Natl Acad Sci USA 85:1086-1090
26. Rossi F, Labourier E, Forné T, Divita G, Derancourt J, Riou JF, Antoine E, Cathala G, Brunei C, Tazi J (1996) Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I. Nature 381:80-82
27. Berget SM, Moore C, Sharp PA (1977) Spliced segments at the 5′ terminus of adenovirus 2 late mRNA. Proc Natl Acad Sci USA 74:3171-3175
28. Krainer AR, Maniatis T, Ruskin B, Green MR (1984) Normal and mutant human β-globin pre-mRNAs are faithfully and efficiently spliced in vitro. Cell 36:993-1005
29. Ruskin B, Krainer AR, Maniatis T, Green MR (1984) Excision of an intact intron as a novel lariat structure during pre-mRNA splicing in vitro. Cell 38:317-331
30. Grabowski PJ, Padgett RA, Sharp PA (1984) Messenger RNA splicing in vitro: an excised intervening sequence and a potential intermediate. Cell 37:415-427
31. Padgett RA, Konarska MM, Grabowski PJ, Hardy SF, Sharp PA (1984) Lariat RNAs as intermediates and products in the splicing of messenger RNA precursors. Science 225:898-903
32. Michel F, Ferat JL (1995) Structure and activities of group II introns. Annu Rev Biochem 64:435-461
33. Cech TR, Bass BL (1986) Biological catalysis by RNA. Annu Rev Biochem 55:599-629
34. Lührmann R, Kastner B, Bach M (1990) Structure of spliceosomal snRNPs and their role in pre-mRNA splicing. Biochim Biophys Acta 1087:265-292
35. Lührmann R (1988) snRNP proteins. In: Birnstiel ML (ed) Structure and function of major and minor small nuclear ribonucleoprotein paticles. Springer. Berlin Heidelberg New York, pp 71-99
36. Guthrie C, Patterson B (1988) Spliceosomal snRNAs. Annu Rev Genet 22:387-419
37. Madhani HD, Guthrie C (1994) Dynamic RNA-RNA interactions in the spliceosome. Annu Rev Genet 28:1-26
38. Sontheimer EJ, Steitz JA (1993) The US and U6 small nuclear RNAs as active site components of the spliceosome. Science 262:1989-1996
39. Wise JA (1993) Guides to the heart of the spliceosome. Science 262:1978-1979
40. Schmelzer C, Muller MW (1987) Self-splicing of group II introns in vitro: lariat formation and 3′ splice site selection in mutant RNAs. Cell 51:753-762
41. Michel F, Umesono K, Ozeki H (1989) Comparative and functional anatomy of group H catalytic introns. Gene 8222:5-30
42. Jarrell KA, Dietrich RC, Perlman PS (1988) Group II intron domain 5 facilitates a trans-splicing reaction. Mol Cell Biol 8:2361-2366
43. Koch JL, Boulanger SC, Dib HS, Hebbar SK, Perlman PS (1992) Group II introns deleted for multiple substructures retain self-splicing activity. Mol Cell Biol 12:1950-1958
44. Dib-Hajj SD, Boulanger SC, Hebbar SK, Peebles CL, Franzen JS, Perlman PS (1993) Domain 5 interacts with domain 6 and influences the second transesterification reaction of group II intron self-splicing. Nucleic Acids Res 21:1797-1804
45. Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41-54
46. Mayeda A, Krainer AR (1992) Regulation of alternative premRNA splicing by hnRNP A1 and splicing factor SF2. Cell 68:365-375
47. Krämer A (1996) The sructure and function of proteins involved in mammalian pre-mRNA splicing. Annu Rev Biochem 65:367-409
48. Brosi R, Gröning K, Behrens SE, Lührmann R, Krämer A (1993) Interaction of mammalian splicing factor SF3a with U2 snRNP and relation of its 60-kD subunit to yeast PRP9. Science 262:102-105
49. Screaton GR, Càceres JF, Mayeda A, Bell MV, Plebanski M, Jackson DG, Bell JI, Krainer AR (1995) identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J 14:4336-4349
50. Shannon K, Guthrie C (1991) Suppressors of a U4 snRNA mutation define a novel U6 snRNP protein with RNA-binding motifs. Genes Dev 5:773-785
51. Patton JG, Mayer SA, Tempst P, Nadal-Ginard B (1991) Characterization and molecular cloning of polypyrimidine tact-binding protein: a component of a complex necessary for pre-mRNA splicing. Genes Dev 5:1237-1251
52. Patton JG, Porro EB, Galceran J, Tempst P, Nadal-Ginard B (1993) Cloning and characterization of PSF, a novel pre-mRNA splicing factor. Genes Dev 7:393-406
53. Fu XD, Maniatis T (1992) Isolation of a complementary DNA that encodes the mammalian splicing factor SC35. Science 256:535-538
54. Krainer RK, Mayeda A, Kozak D (1991) Functional expression of cloned human splicing factor SF2: Homology to RNA-binding proteins. U1 70 K, and Drosophila splicing regulators. Cell 66:383-394
55. Ge H, Zuo P, Manley JL (1991) Primary structure of the human splicing factor ASF reveals similarities with drosophila regulators. Cell 66:373-382
56. Amerein H, Gorman M, Nöthinger R (1988) The sex-determining gene tra-2 of Drosophila encodes a putative RNA binding domain. Cell 55:1025-1035
57. Boggs RT, Gregor P, Idriss S, Belote JM, McKeown M (1987) Regulation of sexual differentiation in D. melanogaster via alternative splicing of RNA from the transformer gene. Cell 50:739-747
58. Goralski TJ, Edström JE, Baker BS (1989) The sex determination locus transformer-2 of drosophila encodes a polypepetide with similarity to RNA binding protein. Cell 56:1011-1018
59. Company M, Arenas J, Abelson J (1991) Requirement of the RNA helicase-like protein PRP22 for release of messenger RNA from spliceosomes. Nature 349:487-493
60. Strauss EJ, Guthrie C (1991) A cold- sensitive mRNA splicing mutant is a member of the RNA helicase gene family. Genes Dev 5:629-641
61. Burgess S, Couto JR, Guthrie C (1990) A putative ATP binding protein influences the fidelity of branchpoint recognition in yeast splicing. Cell 60:705-717
62. Chen JH, Lin RJ (1990) The yeast PRP2 protein, a putative RNA-dependent ATPase, shares extensive sequence homology with two other pre-mRNA splicing factors. Nucleic Acids Res 18:6447
63. Dalbadie-McFarland G, Abelson J (1990) PRP5: A helicase-like protein required for mRNA splicing in yeast. Proc Natl Acad Sci USA 87:4236-4240
64. Schwer B, Guthrie C (1991) PRP16 is an RNA-dependent ATPase that interacts transiently with the spliceosome. Nature 349:494-499
65. Kim SH, Lin RJ (1993) Pre-mRNA splicing within an assembled yeast spliceosome requires an RNA-dependent ATPase and ATP hydrolysis. Proc Natl Acad Sci USA 90:888-892
66. Strauss EJ, Guthrie C (1994) PRP28, a 'DEAD-box' protein, is required for the first step of mRNA splicing in vitro. Nucleic Acids Res 22:3187-3193
67. Linder P, Lasko PF, Ashburner M, Leroy P, Nielsen PJ, Nishi K, Schnier J, Slonimski PP (1989) Bearth with the DEAD box. Nature 337:121-122
68. Umen JG, Guthrie C (1995) The second catalytic step of pre-mRNA splicing. RNA 1:869-885
69. Tazi J, Daugeron MC, Cathala G, Brunei C, Jeanteur P (1992) Adenosine phosphorothioates (ATPaS and ATPgS) differentially affect the two steps of mammalian pre-mRNA splicing. J Biol Chem 267:4322-4326
70. Tazi J, Kornstädt U, Rossi F, Jeanteur P, Cathala G, Brunei C, Lührmann R (1993) Thiophosphorylation of U1-70 K protein inhibits pre-mRNA splicing. Nature 363:283-285
71. Mermoud JE, Cohen PTW, Lamond AI (1994) Regulation of mammalian spliceosome assembly by a protein phosphorylation mechanism. EMBO J 13:5679-56888
72. Mermoud JE, Calvio C, Lamond AI (1994) Uncovering the role of Ser/Thr protein phosphorylation in nuclear pre-mRNA splicing. Adv Prot Phosphatases 8:99-118
73. Mermoud JE, Cohen PTW, Lamond AI (1992) Ser/Thr-specific protein phosphatases are required for both catalytic steps of pre-mRNA splicing. Nucleic Acids Res 20:5263-5269
74. Woppmann A, Will CL, Konstädt U, Zuo P, Manley JM, Lührmann R (1993) Identification of an snRNP-associated kinase activity that phosphorylates arginine/serine rich domains typical of splicing factors. Nucleic Acids Res 21: 2815-2822
75. Rio DC (1993) Splicing of pre-mRNA: mechanism, regulation and role in developement. Curr Opin Genet Dev 3:574-584
76. Dreyfuss G, Matunis MJ, Pinol-Roma S, Burd CG (1993) hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem 62:289-321
77. Mattaj IW (1989) A binding consensus: RNA-protein interactions in splicing, snRNPs, and sex. Cell 57:1-3
78. Mattaj IW (1993) RNA recognition: A family matter? Cell 73:837-840
79. Frankel AD, Mattaj IW, Rio DC (1991) RNA protein interactions. Cell 67:1041-1046
80. Burd CG, Dreyfuss G (1994) conserved structures and diversity of functions of RNA-bindina proteins. Science 265: 615-620
81. Krainer RK, Mayeda A, Kozak D (1991) Functional expression of cloned human splicing factor SF2: homology to RNA-binding proteins. U1 70 K. and drosophila splicing regulators. Cell 66:383-394
82. Theissen H, Etzerodt M, Reuter R, Schneider C, Lottspeich F, Argos P, Lührmann R, Philipson L (1986) Cloning of the human cDNA for the U1 RNA-associated 70 K protein. EMBO J 5:3209-3217
83. Query CC, Bentley RC, Keene JD (1989) A common RNA recognition motif identified within a defined U1 RNA binding domain of the 70 K U1 snRNP protein. Cell 57:89-101
84. Zamore PD, Green MR (1989) Identification, purification, and biochemical characterization of U2 small nuclear ribonucleoprotein auxiliary factor. Proc Natl Acad Sci USA 86: 9243-9247
85. Zamore PD, Green MR (1991) Biochemical characterization of U2 snRNP auxiliary factor: an essential pre-mRNA splicing factor with a novel intranuclear distribution. EMBO J 10:207-214
86. Wu JY, Maniatis T (1993) Specific interactions between proteins implicated in splice site selection and regulated alternative splicing. Cell 75:1061-1070
87. Amerein H, Hedley ML, Maniatis T (1994) The role of specific protein-RNA and protein-protein interactions in positive and negative control of pre-mRNA splicing by transformer 2. Cell 76:735-746
88. Zuo P, Maniatis T (1996) The splicing factor U2AF35 mediates critical protein-protein interactions in constitutive and enhancer-dependent splicing. Genes Dev 10:1356-1368
89. Reed R (1996) Initial splice-site recognition and pairing during pre-mRNA splicing. Curr Opin Genet Dev 6:215-220
90. Kohtz JD, Jamison SF, Will CL, Zuo P, Lührmann R, Garcia-Blanco MA, Manley JL (1994) Protein-protein interactions and 5′-splice-site recognition in mammalian mRNA precursors. Nature 368:119-124
91. Caceres JF, Stamm S, Helfman DM, Krainer AR (1994) Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 265:1706-1709
92. Ge H, Manley JL (1990) A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro. Cell 62:25-34
93. Tian M, Maniatis T (1993) A splicing enhancer complex controls alternative splicing of doublesex pre-mRNA. Cell 74: 105-114
94. Krainer AR, Conway GC, Kozak D (1990) The essential premRNA splicing factor SF2 influences 5′ splice site selection by activating proximal sites. Cell 62:35-42
95. Fu XD, Mayeda A, Maniatis T, Krainer AR (1992) General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5′ and 3′ splice site selection. Proc Natl Acad Sci USA 89:11224-11228
96. Cardinali B, Cohen PTW, Lamond AI (1994) Protein phosphatase 1 can modulate alternative 5′ splice site selection in a HeLa splicing extract. FEBS Lett 352:276-280
97. Carmo-Fonceca M, Pepperkok R, Sproat BS, Ansorge W, Swanson MS, Lamond AI (1991) In vivo detection of snRNP-rich organelles in the nuclei of mammalian cells. EMBO J 10:1863-1873
98. Jiménez-Garcia LF, Spector DL (1993) In vivo evidence that transcription and splicing are coordinated by a recruiting mechanism. Cell 73:47-59
99. Baurén G, Wieslander L (1994) Splicing of Balbiani ring 1 gene pre-mRNA occurs simultaneously with transcription. Cell 76:183-192
100. Spector DL (1993) Macromolecular domains within the cell nucleus. Ann Rev Cell Biol 9:265-315
101. Nyman U, Hallman H, Hadlaczky G, Pettersson I, Sharp G, Ringertz N (1986) Intranuclear localisation of snRNP antigens. J Cell Biol 102:137-144
102. Huang MS, Spector DL (1992) Will the real splicing sites please light up? Curr Biol 2:188-190
103. Bregman DB, Du L, Van derZee S, Warren SL (1995) Transcription dependent redistribution of the large subunit of RNA polymerase II to discrete nuclear domains. J Cell Biol 129:287-298
104. Mortillaro MJ, Blencowe BJ, Wei X, Nakayasu H, Du L, Warren SL, Sharp PA, Berezney R (1996) A hyperphosphorylated form of the large subunit of RNA polymerase II is associated with splicing complexes and the nuclear matrix. Proc Natl Acad Sci USA 93:8253-8257
105. Fakan S, Leser GP, Martin TE (1984) Ultrastructural distribution of nuclear ribonucleoproteins as visualized by immunocytochemistry. J Cell Biol 98:358-363
106. Spector DL, Fu XD, Maniatis T (1991) Associations between distinct pre-mRNA splicing components and the cell nucleus. EMBO J 10:3467-3481
107. Spector DL (1990) Higher order nuclear organization: three-dimensional distribution of small nuclear ribonuicleoprotein particles. Proc Natl Acad Sci USA 87:147-151
108. Misteli T, Spector DL (1996) Serine/threonine phosphatase 1 modulates the subnuclear distribution of pre-mRNA splicing factors. Mol Biol Cell 7:1559-1572
109. Woppmann A, Patschinsky T, Bringmann P, Godt F, Lührmann R (1990) Characterisation of human and murine snRNP proteins by two-dimensional gel electrophoresis and phosphopeptide analysis of U1-specific 70 K protein variants. Nucleic Acids Res 18:4427-4438
110. Gui J-F, Tronchère H, Chandler SD, Fu X-D (1994) Purification and characterization of a kinase specific for the serine-and arginine-rich pre-mRNA splicing factors. Proc Natl Acad Sci USA 91:10824-10828
111. Zahler AM, Neugebauer KM, Lane WS, Roth MB (1993) Distinct functions of SR proteins in alternative pre-mRNA splicing. Science 260:219-222
112. Hanes J, Von der Kammer H, Klaudiny J, Scheit KH (1994) characterization by cDNA cloning of two new human protein kinases: Evidence by sequence comparison of a new family of mammalian protein kinases. J Mol Biol 244:665-672
113. Castora FJ, Kelly WG (1986) ATP inhibits nuclear and mithochondrial type I topoisomerases from human leukemia cells. Proc Natl Acad Sci USA 83:1680-1684
114. D'Arpa P, Machlin PS, Ratrie H, Rothfield NF, Cleveland DW, Earnshaw WC (1988) cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment. Proc Natl Acad Sci USA 85:2543-2547
115. Gupta M, Fujimori A, Pommier Y (1995) Eukaryotic DNA topoisomerases I. Biochim Biophys Acta 1262:1-14
116. Stewart L, Ireton GC, Champoux JJ (1996) The domain organization of human topoisomerase I. J Biol Chem 271:7602-7608
117. Alsner J, Svejstrup JQ, Kjeldsen E, Sorensen BS, Westergaard O (1992) Identification of an N-terminal domain of eukaryotic DNA topoisomerase I dispensable for catalytic activity but essential for in vivo function. J Biol Chem 267:12408-12411
118. Liu LF, Miller KG (1981) Eucaryotic DNA topoisomerases: two forms of type I DNA topoisomerases from HeLa cell nuclei. Proc Natl Acad Sci USA 78:3487-3491
119. Champoux JJ (1976) Evidence for an intermediate with a single-stand break in the reaction catalyzed by the DNA untwisting enzyme. Proc Natl Acad Sci USA 73:3488-3491
120. Champoux JJ (1990) Mechanistic aspects of type-I topoisomerases. In: Wang JC, Cozzarelli NR (eds) DNA topology and its biological effects. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 217-249
121. Champoux JJ (1977) Strand breakage by the DNA untwisting enzyme results in covalent attachement of the enzyme to DNA. Proc Natl Acad Sci USA 74:3800-3804
122. Champoux JJ (1978) Mechanism of the reaction catalyzed by the DNA untwisting enzyme: attachment of the enzyme to 3′-terminus of the nicked DNA. J Mol Biol 118:441-446
123. Champoux JJ (1981) DNA is linked to the rat liver DNA nick-closing enzyme by a phosphodiester bond to tyrosine. J Biol Chem 256:4805-4809
124. Lynn RM, Bjornsti MA, Caron PR, Wang JC (1989) Peptide sequencing and site-directed mutagenesis identify tyrosine-727 as the active site tyrosine of Saccharomyces cerevisiae DNA topoisomerase I. Proc Natl Acad Sci USA 86:3559-3563
125. Madden KR, Champoux JJ (1992) Overexpression of human topoisomerase I in baby hamster kidney cells: hypersensitivity of clonal isolates to camptothecin. Cancer Res 52:525-532
126. Champoux JJ, Dulbecco R (1972) An activity from mammalian cells that untwists superhelical DNA: a possible swivel for DNA replication. Proc Natl Acad Sci USA 69:143-146
127. Wang JC (1985) DNA Topoisomerases. Annu Rev Biochem 54:665-697
128. Wang JC (1991) DNA topoisomerases: Why so many? J Biol Chem 266:6659-6662
129. Thrash C, Voelkel K, DiNardo S, Sternglanz R (1984) Identification of Saccharomyces cerevisiae mutants deficient in DNA topoisomerase I activity. J Biol Chem 259:1375-1377
130. Thrash C, Bankier AT, Barrell BG, Sterglanz R (1985) Cloning, characterization, and sequence of the yeast DNA topoisomerase I gene. Proc Natl Acad Sci USA 82:4374-4378
131. Uemura T, Yanagida M (1984) Isolation of type I and II DNA topoisomerase mutants from fission yeast: single and double mutants show different phenotypes in cell growth and chromatin organization. EMBO J 3:1737-1744
132. Sadoff BU, Health-Pagliuso S, Castano IB, Zhu Y, Kieff SF, Christman MF (1995) Isolation of mutants of S. cerevisiae requiring DNA topoisomerase I. Genet 141:465-479
133. Castano IB, Heath-Pagliuso S, Sadoff BU, Fitzhugh DJ, Christman MF (1996) A novel family of TRF (DNA topoisomerase I-related function) genes required for proper nuclear segregation. Nucleic Acids Res 24:2404-2410
134. Lee MP, Brawn SD, Chen A, Hsieh TS (1993) DNA topoisomerase I is essential in Drosophila melanogaster. Proc Natl Acad Sci USA 90:6656-6660
135. Wu HY, Shyy S, Wang JC, Liu IF (1988) Transcription generates positively and negatively supercoiled domains in the template. Cell 53:433-440
136. Tsao YP, Wu HY, Liu LF (1989) Transcription-driven supercoiling of DNA: direct biochemical evidence from in vitro studies. Cell 56:111-118
137. Liu LF, Wang JC (1987) Supercoiling of the DNA template during transcription. Proc Natl Acad Sci USA 84:7024-7027
138. Choder M (1991) A general topoisomerase I-dependent transcriptional repression in the stationary phase in yeast. Genes Dev 5:2315-2326
139. Zhang H, Wang JC, Liu LF (1988) Involvement of DNA topoisomerase I in the transcription of human ribosomal RNA genes. Cell 85:1060-1064
140. Brill SJ, Sternglanz R (1988) Transcription-dependent DNA supercoiling in yeast DNA topoisomerase mutants. Cell 54:403-411
141. Garg LC, DiAngelo S, Jacob ST (1987) Role of DNA topoisomerase I in the transcription of supercoiled rRNA gene. Proc Natl Acad Sci USA 84:3185-3188
142. Drolet M, Wu HY, Liu LF (1994) Roles of DNA topoisomerases in transcription. Adv Pharmacol 29:135-146
143. Kim RA, Wang JC (1989) Function of DNA topoisomerases as replication swivels in S. cerevisiae. J Mol Biol 208:257-267
144. Yang L, Wold MS, Li JJ, Kelly TJ, Liu LF (1987) Roles of DNA topoisomerases in simian virus 40 DNA replication in vitro. Proc Natl Acad Sci USA 84:950-954
145. Brill SJ, DiNardo S, Voelkel-Meiman K, Sternglanz R (1987) Need for DNA topoisomerase activity as a swivel for DNA replication and for transcription of ribosomal DNA. Nature 326:414-416
146. Tsao YP, Russo A, Nyamuswa G, Silber R, Liu LF (1993) Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system. Cancer Res 53:5908-5914
147. Snapka RM (1986) Topoisomerase inhibitors can selectively interfere with different stages of simian virus 40 DNA replication. Mol Cell Biol 6:4221-4227
148. Champoux JJ (1988) Topoisomerase I is preferentially associated with isolated replicating simian virus 40 molecules after treatment of infected cells with camptothecin. J Virol 62:3675-3683
149. Hsiang YH, Lihou MG, Liu LF (1989) Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res 49:5077-5082
150. Christman MF, Dietrich FS, Fink GR (1993) Mitotic recombination in the rDNA of S. cerevisiae is suppressed by the combined action of DNA topoisomerase I and II. Cell 55:413-425
151. Wang JC, Caron PR, Kim RA (1990) The role of DNA topoisomerases in recombination and genomic stability: a double-edged sword? Cell 62:403-406
152. Kim RA, Wang JC (1989) A subthreshold level of DNA topoisomerases leads to the excision of yeast rDNA as extrachromosomal rings. Cell 57:975-985
153. Zhu J, Schiestl RH (1996) Topoisomerase I involvement in illegitimate recombination in Saccharomyces cerevisiae. Mol Cell Biol 16:1805-1812
154. Aratani Y, Andoh T, Koyama H (1996) Effects of DNA topoisomerase inhibitors on nonhomologous and homologous recombination in mammalian cells. Mutat Res 362:181-191
155. Wallis JW, Chrebet G, Brodsky G, Rolfe M, Rothstein R (1989) A hyper-recombination mutation in S. cerevisiae identifies a novel eukaryotic topoisomerase. Cell 58:409-419
156. Bullock P, Champoux JJ, Botchan M (1985) Association of crossover points with topoisomerase I cleavage sites: a model for nonhomologous recombination. Science 230:954-958
157. Javaherian K, Liu LF (1983) Association of eukaryotic DNA topoisomerase I with nucleosomes and chromosomal proteins. Nucleic Acids Res 11:461-472
158. Christman MF, Dietrich FS, Levin NA, Sadoff BU, Fink GR (1993) The rRNA-encoding DNA array has an altered structure in topoisomerase I mutants of S. cerevisiae. Proc Natl Acad Sci USA 90:7637-7641
159. Hanai R, Caron PR, Wang JC (1996) Human TOP3: a single-copy gene encoding DNA topoisomerase III. Proc Natl Acad Sci USA 93:3653-3657
160. Uemura T, Morino K, Uzawa S, Shiozaki K, Yanagida M (1987) Cloning and sequencing of Schizosaccharomyces pombe DNA topoisomerase I gene, and effect of gene disruption. Nucleic Acids Res 15:9727-9739
161. Uemura T, Morikawa K, Yanagida M (1986) The nucleotide sequence of the fission yeast DNA topoisomerase II gene: structural and functional relationships to other DNA topoisomerases. EMBO J 5:2355-2361
162. Goto T, Wang JC (1984) Yeast DNA topoisomerase II is encoded by a single-copy, essential gene. Cell 36:1073-1080
163. Uemura T, Ohkura H, Adachi Y, Morino K, Shiozaki K, Yanagida M (1987) DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe. Cell 50:917-925
164. DiNardo S, Voelkel K, Sternglanz R (1984) DNA topoisomerase II mutant of Sacchammvces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication. Proc Natl Acad Sci USA 81:2616-5620
165. Holm C, Goto T, Wang JC, Botstein D (1985) DNA topoisomerase II is required at the time of mitosis in yeast. Cell 41:553-563
166. Muller MT, Pfund WP, Mehta VB, Trask DK (1985) Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA. EMBO J 4:1237-1243
167. Buckwalter CA, Lin AH, Tanizawa A, Pommier YG, Cheng YC, Kaufmann SH (1996) RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase I. Cancer Res 56:1674-1681
168. Pommier Y (1996) Eukaryotic DNA topoisomerase I: genome gatekeeper and its intruders, camptothecins. Semin Oncol 23:3-10
169. D'Arpa P, Liu LF (1989) Topoisomerase-targeting antitumor drugs. Biochim Biophys Acta 989:163-177
170. Stewart AF, Herrera RE, Nordheim A (1990) Rapid induction of c-fos transcription reveals quantitative linkage of RNA polymerase II and DNA topoisomerase I enzyme activities. Cell 60:141-149
171. Kroeger PE, Rowe TC (1989) Interaction of topoisomerase I with the transcribed region of the Drosophila HSP 70 heat shock gene. Nucleic Acids Res 17:8495-8509
172. Cavalli G, Bachmann D, Thoma F (1996) Inactivation of topoisomerases affects transcription-dependent chromatin transitions in rDNA but not in a gene transcribed by RNA polymerase II. EMBO J 15:590-597
173. Rose KM, Szopa J, Han FS, Cheng YC, Richter A, Scheer U (1988) Association of DNA topoisomerase I and RNA polymerase I: a possible role for topoisomerase I in ribosomal gene transcription. Chromosoma 96:411-416
174. Bharti AK, Olson MOJ, Kufe DW, Rubin EH (1996) Identification of a Nucleolin binding site in human topoisomerase I. J Biol Chem 271:1993-1996
175. Gobert C, Bracco L, Rossi F, Olivier M, Tazi J, Lavelle F, Larsen AK, Riou JF (1996) Modulation of DNA topoisomerase I activity by p53. Biochemistry 35:5778-5786
176. Merino A, Madden KR, Lane WS, Champoux JJ, Reinberg D (1993) DNA topoisomerase I is involved in both repression and activation of transcription. Nature 365:227-232
177. Kretzschmar M, Meisterernst M, Roeder RG (1993) Identification of human DNA topoisomerase I as a cofactor for activator-dependent transcription by RNA polymerase II. Proc Natl Acad Sci USA 90:11508-11512
178. Wang JC, Lynch AS (1993) Transcription and DNA supercoiling. Curr Opin Genet Dev 3:764-768
179. Madden KR, Stewart L, Champoux JJ (1995) Preferential binding of human topoisomerase I to superhelical DNA. EMBO J 14:5399-5409
180. Champoux JJ (1992) Topoisomerase I is preferentially associated with normal SV40 replicative intermediates, but is associated with both replicating and nonreplicating SV40 DNAs which are deficient in histones. Nucleic Acids Res 20:3347-3352
181. Lavelle F, Bissery MC, Andre S, Roquet F, Riou JF (1996) Preclinical evaluation of CPT-11 and its active metabolite SN- 38. Semin Oncol 23:11-20
182. Potmesil M, Khon KW (1991) DNA topoisomerases in cancer. Oxford University Press, New York
183. Liu LF (1989) DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 58:351-375
184. Hsiang YH, Wu HY, Liu LF (1988) Topoisomerases: novel therapeutic targets in cancer chemotherapy. Biochem Pharmacol 37:1801-1812
185. Pommier Y (1993) DNA topoisomerase I and II in cancer chemotherapy: update and perspectives. Cancer Chemother Pharmacol 32:103-108
186. Froelich-Ammon SJ, Osheroff N (1995) Topoisomerase poisons: harnessing the dark side of enzyme mechanism. J Biol Chem 270:21429-21432
187. Nitiss J, Wang JC (1988) DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc Natl Acad Sci USA 85:7501-7505
188. Hsiang YH, Liu LF (1988) Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancerdrug camptothecin. Cancer Res 48:1722-1726
189. Bjornsti MA, Knab AM, Benedetti P (1994) Yeast Saccharomyces cerevisiae as a model system to study the cytotoxic activity of the antitumor drug camptothecin. Cancer Chemother Pharmacol 34:1-5
190. Bjornsti MA, Benedetti P, Viglianti GA, Wang JC (1989) Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin. Cancer Res 49:6318-6323
191. Giovanella BC, Stehlin JS, Wall ME, Wani MC, Nicholas AW, Liu LF, Silber R, Potmesil M (1989) DNA topoisomerase I - targeted chemotherapy of human colon cancer in xenografts. Science 246:1046-1048
192. Eng WK, Faucette L, Johnson RK, Sternglanz R (1988) Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin. Mol Pharmacol 34:755-760
193. Hertzberg RP, Caranfa MJ, Hecht SM (1989) On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. Biochemistry 28:4629-4638
194. Andersen AH, Svejstrup JQ, Westergaard O (1994) The DNA binding, cleavage, and religation reactions of eukaryotic topoisomerases I and II. Adv Pharmacol 29:83-101
195. Kjeldsen E, Bonven BJ, Andoh T, Ishii K, Okada K, Bolund L, Westergaard O (1988) Characterization of a camptothecin-resistant human DNA topoisomerase I. J Biol Chem 263: 3912-3916
196. Porter SE, Champoux JJ (1989) The basis for camptothecin enhancement of DNA breakage by eucaryotic topoisomerase I. Nucleic Acids Res 17:8521-8532
197. Tanizawa A, Kohn KW, Kohlhagen G, Leteurtre F, Pommier Y (1995) Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives. Biochemistry 34:7200-7206
198. Hsiang YH, Hertzberg R, Hecht S, Liu LF (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 260:14873-14878
199. Liu LF, D'Arpa P (1992) Topoisomerase-targeting antitumor drugs: mechanisms of cytotoxicity and resistance. Important Adv Oncol 79-89
200. Morris EJ, Geller HM (1996) Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity. J Cell Biol 134: 757-770
201. Solary E, Dubrez L, Eymin B, Bertrand R, Pommier Y (1996) Apoptosis of human leukemic cells induced by topoisomerase I and II inhibitors. Bull Cancer (Paris) 83:205-212
202. Tsao YP, D'Arpa P, Liu LF (1992) The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B. Cancer Res 52:1823-1829
203. D'Arpa P, Beardmore C, Liu LF (1990) Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. Cancer Res 50:6919-6924
204. Holm C, Covey JM, Kerrigan D, Pommier Y (1989) Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. Cancer Res 49:6365-6368
205. Fujimori A, Harker WG, Kohlhagen G, Hoki Y, Pommier Y (1995) Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin. Cancer Res 55:1339-1346
206. Tanizawa A, Beitrand R, Kohlhagen G, Tabuchi A, Jenkins J, Pommier Y (1993) Cloning of Chinese hamster DNA topoisomerase I cDNA and identification of a single point mutation responsible for camptothecin resistance. J Biol Chem 268:25463-25468
207. Knab AM, Fertala J, Bjornsti MA (1993) Mechanisms of camptothecin resistance in yeast DNA topoisomerase I mutants. J Biol Chem 268:22322-22330
208. Kubota N, Kanzawa F, Nishio K, Takeda Y, Ohmori T, Fujiwara Y, Terashima Y, Saijo N (1992) Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line. Biochim Biophys Res Commun 188:571-577
209. Rubin E, Pantazis P, Bharti A, Toppmeyer D, Giovanella B, Kufe D (1994) Identification of a mutant human topoisomerase I with intact catalytic activity and resistance to 9-nitrocamptothecin. J Biol Chem 269:2433-2439
210. Benedetti P, Fiorani P, Capuani L, Wang JC (1993) Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine. Cancer Res 53:4343-4348
211. Blaney SM, Balls FM, Cole DE, Craig C, Reid JM, Ames MM, Krailo M, Reaman G, Hammond D, Poplack DG (1993) Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion. Cancer Res 53:1032-1036
212. Komuro H, Li P, Tsuchida Y, Yokomori K, Nakajima K, Aoyama T, Kaneko M, Kaneda N (1994) Effects of CPT-11 (a unique DNA topoisomerase I inhibitor) on a highly malignant xeno-transplanted neuroblastoma. Med Pediatr Oncol 23:487-492
213. Shinkai T, Arioka H, Kunikane H, Eguchi K, Sasaki Y, Tamura T, Ohe Y, Oshita F, Nishio M, Karato A (1994) Phase I clinical trial of irinotecan (CPT-11). Cancer Res 54:2636-2642
214. Saijo N, Nishio K, Kubola N, Kanzawa F, Shinkai T, Karato A, Sasaki Y, Eguchi K, Tamura T, Ohe Y (1994) 7-Ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxy camptothecin: mechanism of resistance and clinical trials. Cancer Chemother Pharmacol 34:112-117
215. de Form M, Bugat R, Chabot GG, Culine S, Extra JM, Gouyette A, Madelaine I, Marty ME, Mathieu-Boue A (1994) Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients. Cancer Res 54:4347-4354
216. Houghton PJ, Cheshire PJ, Hallman JC, Bissery MC, Mathieu-Boue A, Houghton JA (1993) Therapeutic efficacy of the topoisomerase 1 inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase 1 inhibitor 9-dimethylaminomethyl-10-hydroxycamptothecin. Cancer Res 53:2823-2829
217. Kawato Y, Aonuma M, Hirota Y, Kuga H, Sato K (1991) Intracellular roles of SN-38, a metabolite of the camplothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res 51:4187-4191
218. Kaneda N, Nagata H, Furuta T, Yokokura T (1990) Metabolism and pharmacokinetics of the camptothecin analogue CPT- 11 in the mouse. Cancer Res 50:1715-1720
219. Emerson DL, Besterman JM, Brown HR, Evans MG, Eeitner PP, Luzzio MJ, Shatter JE, Sternbach DD, Uehling D, Vuong A (1995) In vivo antitumor activity of two new seven-substituted water- soluble camptothecin analogues. Cancer Res 55:603-609
220. Mi Z, Malak H, Burke TG (1995) Reduced albumin binding promotes the stability and activity of topotecan in human blood. Biochemistry 34:13722-13728
221. Subramanian D, Kraut E, Staubus A, Young DC, Muller MT (1995) Analysis of topoisomerase I/DNA complexes in patients administered lopotecan. Cancer Res 55:2097-2103
222. Blaney SM, Cole DE, Balis FM, Godwin K, Poplack DG (1993) Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in non human primates. Cancer Res 53:725-727
223. Muttern MR, Hofmann GA, McCabe FE, Johnson RK (1991) Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864). Cancer Res 51:5813-5826
224. Uckun FM, Stewart CF, Reainan G, Chelstrom EM, Jin J, Chandan-Eanglie M, Waddick KG, White J, Evans WE (1995) In vitro and in vivo activity of topotecan against human B-lineage acute lymphoblastic leukemia cells. Blood 85:2817-2828
225. Charcosset JY, Soues S, Eaval F (1993) [Poisons of DNA topoisomerases I and II]. Bull Cancer (Paris) 80:923-954
226. Riou JF, Pommier Y (1994) [Pleiotropic resistance associated with topoisomerases]. Bull Cancer (Paris) 81:62s-68s